SEC Form 4 · accession 0001834423-26-000008
AbCellera Biologics Inc. · ABCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John S. Montalbano
Director
Period of report
Aug 18, 2026
Accepted (ET)
Aug 18, 2026 · 2:45 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001703057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 18, 2026 | P | 10,000 | $11.03 | A | 251,000 | D | |
| Common Shares | holding | — | — | — | 5,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.